FAQ

17-hydroxywortmannin

 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1987-2010
0119872010

Related topics

Related topics

1 relation

Broader (1)

Androstadienes

Related mentions per year

Related mentions per year

1980-2014
19801990200020102020
17-hydroxywortmannin
Androstadienes

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2010
2010
Hybrid inhibitors of phosphatidylinositol 3-kinase (PI3K) and the mammalian target of rapamycin (mTOR): design, synthesis, and superior antitumor activity of novel wortmannin-rapamycin conjugates.
Hyperactivation of the PI3K/AKT/mTOR signaling pathway is common in cancer, and PI3K and mTOR act synergistically in promoting… (More)
  • figure 1
  • table 1
  • figure 2
  • figure 4
  • figure 5
Is this relevant?
2008
2008
Synthesis and structure-activity relationships of ring-opened 17-hydroxywortmannins: potent phosphoinositide 3-kinase inhibitors with improved properties and anticancer efficacy.
The phosphoinositide 3-kinase (PI3K) signaling pathway is frequently up-regulated in human cancer and is a promising target for… (More)
  • figure 1
  • table 1
  • table 2
  • figure 4
  • figure 2
Is this relevant?
2006
2006
Pegylated wortmannin and 17-hydroxywortmannin conjugates as phosphoinositide 3-kinase inhibitors active in human tumor xenograft models.
Phosphoinositide 3-kinase (PI3K) is an important target for cancer chemotherapy due to the deregulation of its signaling pathway… (More)
Is this relevant?
2005
2005
PWT-458, a novel pegylated-17-hydroxywortmannin, inhibits phosphatidylinositol 3-kinase signaling and suppresses growth of solid tumors.
Deregulated phosphatidylinositol 3-kinase (PI3K) signaling pathway is widely implicated in tumor growth and resistance to… (More)
Is this relevant?
Highly Cited
1994
Highly Cited
1994
Wortmannin binds specifically to 1-phosphatidylinositol 3-kinase while inhibiting guanine nucleotide-binding protein-coupled receptor signaling in neutrophil leukocytes.
Wortmannin (WT) and its derivative 17-hydroxywortmannin (HWT) inhibit at nanomolar concentrations superoxide formation and… (More)
Is this relevant?
1993
1993
Serine/threonine kinases in signal transduction in response to thrombin in human platelets. Use of 17-hydroxywortmannin to discriminate signals.
Although the importance of protein kinases in platelet activation, particularly protein kinase C (PKC), is well established there… (More)
Is this relevant?
1991
1991
Effects of 17-hydroxywortmannin on serine/threonine-protein kinases in human blood platelets.
Protein kinases are involved in signal transduction in human blood platelets. A number of renaturable protein kinases have… (More)
Is this relevant?
1990
1990
Corresponding oscillations in neutrophil shape and filamentous actin content.
Human neutrophils pretreated with 17-hydroxywortmannin responded to the chemotactic agonist formyl-Met-Leu-Phe with a transient… (More)
Is this relevant?
Highly Cited
1988
Highly Cited
1988
Mechanism of neutrophil activation by NAF, a novel monocyte-derived peptide agonist.
The rise in cytosolic free Ca2+, shape change, superoxide formation, and granule exocytosis induced in human neutrophils by N… (More)
Is this relevant?
1988
1988
Two transduction sequences are necessary for neutrophil activation by receptor agonists.
The effects of 17-hydroxywortmannin (HWT), a powerful inhibitor of the respiratory burst associated with phagocytosis (Baggiolini… (More)
Is this relevant?